ecancer

ECCO 15 - ESMO 34 Chairs: Why join us in Berlin?

Why attend ECCO 15 - ESMO 34?

22 Jul 2009

The Oncopolicy Roundtable: ECCO's President and special guests highlight key issues

ECCO 15 - ESMO 34

22 Jul 2009

AACR 2009: Common genetic variations and predisposition to cancer

Prof Bruce Ponder - Cancer Research UK, Cambridge Institute

14 May 2009

AACR 2009: 100 years of AACR

Dr Margaret Foti - CEO of the American Association for Cancer Research

14 May 2009

Bacteria as agents to initiate potent anti-tumour activity

Dr Maria Rescigno - Deptartment of Experimental Oncology, European Institute of Oncology, Milan

31 Mar 2009

ECCO 15 - ESMO 34 Executive Scientific Programme Committee

ECCO-ESMO Roundtable discussion - Full Version

16 Feb 2009

S. Croce General Hospital

Dr Marco Merlano

3 Dec 2008

Cetuximab and docetaxal for squamous cell cancer of the head and neck, from ASCO 2008

Professor Jan B. Vermorken

27 Nov 2008

More from ecancer